Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 6, Number 6—December 2000

Dispatch

Genotypic Analysis of Multidrug-Resistant Salmonella enterica Serovar Typhi, Kenya

Samuel Kariuki*†Comments to Author , Charles Gilks†, Gutura Revathi‡, and C. Anthony Hart†
Author affiliations: *Kenya Medical Research Institute, Nairobi, Kenya; †University of Liverpool, Liverpool, UK; ‡Kenyatta National Hospital, Nairobi, Kenya

Main Article

Figure 2

XbaI restriction endonuclease fragment patterns of representative Salmonella Typhi isolates from various countries. Lanes 1 and 19, molecular size standard; Lane 2, B1 from Bangladesh; Lane 3, I1 from India; Lanes 4 and 5, K1 and K2 from Kuwait; Lanes 6, 7, 8, and 9, M1, M2, M3, and M4 from Malaysia; Lanes 10, 11, 12, 13, and 14, Q1, A2, A3, A4, and A5 from Quetta; Lanes 15, 16, 17, and 18, R1, R2, R3, and R4 from Rawalpindi, Pakistan; Lanes 20-24, K1-K5: sensitive S. Typhi from Kenya; and Lanes

Figure 2. XbaI restriction endonuclease fragment patterns of representative Salmonella Typhi isolates from various countries. Lanes 1 and 19, molecular size standard; Lane 2, B1 from Bangladesh; Lane 3, I1 from India; Lanes 4 and 5, K1 and K2 from Kuwait; Lanes 6, 7, 8, and 9, M1, M2, M3, and M4 from Malaysia; Lanes 10, 11, 12, 13, and 14, Q1, A2, A3, A4, and A5 from Quetta; Lanes 15, 16, 17, and 18, R1, R2, R3, and R4 from Rawalpindi, Pakistan; Lanes 20-24, K1-K5: sensitive S. Typhi from Kenya; and Lanes 25 and 26, K6 and K7: multidrug-resistant S. Typhi from Kenya.

Main Article

TOP